NIP7

NIP7 is a nucleolar RNA-binding protein required for pre-rRNA processing and 40S ribosomal subunit maturation (PMID:20798176). Its conserved C-terminal PUA domain mediates specific binding to polyuridine RNA, with defined basic residues required for the interaction across archaeal and eukaryotic orthologues, while the N-terminal domain is structurally distinct; both domains contribute to rRNA interaction (PMID:18001138, PMID:15522784, PMID:39216654). In human cells, depletion slows pre-rRNA processing at site 2, decreasing 34S pre-rRNA and accumulating 26S and 21S species, which disrupts the 40S/60S subunit balance and impairs 18S rRNA maturation (PMID:20798176). NIP7 acts in this pathway together with FTSJ3, with which it physically interacts and shares a loss-of-function pre-rRNA processing phenotype (PMID:22195017). Beyond ribosome biogenesis, NIP7 promotes translation of UBE2C protein without altering its mRNA, and this UBE2C-supporting activity sustains proliferation in anaplastic thyroid cancer cells (PMID:40461291).

1. 2004 Medium

   Establishing the architecture of the human NIP7 homologue framed it as a candidate RNA-binding factor before any RNA function was tested.

   Evidence X-ray crystallography (1.9 Å, MAD) and DALI-based structural homology analysis of human KD93/HSPC031

   PMID:15522784

   Open questions at the time

   • RNA binding inferred from structural homology to PUA-domain enzymes, not directly demonstrated
   • in vivo function not addressed
   • N-terminal domain role undefined
2. 2007 High

   Direct RNA-binding assays converted the structural inference into a defined molecular activity, showing the PUA domain selects polyuridine RNA via specific basic residues conserved across orthologues.

   Evidence PaNip7 crystal structure, structural alignment, site-directed mutagenesis, and in vitro RNA interaction assays in yeast and archaeal Nip7

   PMID:18001138

   Open questions at the time

   • physiological RNA target within pre-ribosome not identified
   • binding tested in vitro, not in cells
   • does not establish processing step affected
3. 2010 High

   Knockdown placed NIP7 in human ribosome biogenesis, localizing it to a specific pre-rRNA processing step and to nucleolar pre-ribosomal particles.

   Evidence siRNA knockdown with pre-rRNA processing analysis, subcellular fractionation, and sucrose gradient sedimentation

   PMID:20798176

   Open questions at the time

   • molecular mechanism of site 2 cleavage promotion unknown
   • direct enzymatic role versus scaffolding not distinguished
   • composition of the associated pre-ribosomal particles not defined
4. 2011 High

   Identifying FTSJ3 as a physical partner connected NIP7 to a defined protein in the same 18S maturation pathway.

   Evidence Yeast two-hybrid, co-immunoprecipitation, colocalization, and FTSJ3 knockdown showing 34S pre-rRNA accumulation

   PMID:22195017

   Open questions at the time

   • stoichiometry and structural basis of the NIP7-FTSJ3 interaction unknown
   • whether they act in a stable complex not established
   • additional pathway partners not mapped
5. 2024 Medium

   Cross-species complementation confirmed functional conservation and implicated NIP7 in 60S subunit biogenesis, while extending rRNA contact to both domains.

   Evidence Yeast complementation and paromomycin resistance, yeast two-hybrid, and nucleic acid interaction assays with Chlamydomonas CrNip7

   PMID:39216654

   Open questions at the time

   • UNC-p and G-patch partners identified only as candidates by yeast two-hybrid
   • 60S role inferred from yeast complementation, not shown in plant or mammalian cells
   • human relevance of 60S involvement untested
6. 2025 Medium

   A translational function downstream of ribosome biogenesis was uncovered, linking NIP7 to UBE2C protein production and to tumor proliferation.

   Evidence siRNA knockdown, SUnSET translation assay, Western blot, qRT-PCR, co-IP, UBE2C-overexpression rescue, and xenograft model in anaplastic thyroid cancer cells

   PMID:40461291

   Open questions at the time

   • mechanism by which NIP7 selectively promotes UBE2C translation unknown
   • whether the effect is direct or a general consequence of ribosome biogenesis loss not resolved
   • single-lab study in one cancer context

• How NIP7's polyuridine-binding PUA domain mechanistically drives site 2 cleavage and the basis for selective UBE2C translational promotion remain unresolved.
• no structure of the human NIP7-containing pre-ribosomal complex
• physiological RNA substrate in cells unmapped
• link between ribosome biogenesis role and UBE2C-specific translation unexplained